A statement from GO2 for Lung Cancer’s President and CEO Laurie Ambrose on the proposed federal budget cuts The President recently submitted a Fiscal Year 2026 budget request that proposes yet again deep cuts to and elimination of key [...]
WASHINGTON, May 1, 2025 – As the nation recognizes May as Women’s Health Month, GO2 for Lung Cancer (GO2) is proud to celebrate a milestone: the Women and Lung Cancer Research and Preventive Services Act of 2025 (H.R. 2319) [...]
GO2 for Lung Cancer remains at the forefront of leading advocacy efforts to restore funding for the Lung Cancer Research Program. In preparation for today’s Senate Appropriations Committee hearing, “Biomedical Research: Keeping America’s Edge in Innovation,” we submitted written [...]
Author: Matthew Reiss, MSE, PhD, Manager, Precision Medicine & Navigation, GO2 for Lung Cancer Question: Why does it take so long for the FDA to approve new drugs? Answer: Whenever a new cancer drug is created, it [...]
People impacted by lung cancer often experience high levels of stress, anxiety, and depression. They can also have greater unmet emotional and physical needs compared to those diagnosed with other types of cancer. GO2 for Lung Cancer is determined [...]
In early March, we surveyed the GO2 community to understand how recent federal executive orders are affecting patients, loved ones, healthcare providers, and researchers. Themes from 239 completed surveys covered 4 key areas: Impact on daily life or work [...]
Question: I’d like to start looking at whether a clinical trial might be good for me, but the process seems overwhelming. Where should I start? What are the best resources for me to understand my options? Answer: Whenever you [...]
The treatment landscape for small cell lung cancer (SCLC) is continually evolving, thanks to ongoing research to improve outcomes and effective therapies. Combining chemotherapy and immunotherapy remains the standard approach, with clinical trials playing a vital role in discovering [...]
GO2 for Lung Cancer's Manager, Economics & Health Policy, Sydney Burchell, advocates for lung cancer to receive equal priority as other cancers in the state’s Comprehensive Control Plans. We sat down with Sydney to learn what inspires her to [...]
Simi Ranajee, PhD, MBA, does not let lung cancer define her. Crowned the first Miss India Worldwide in 1990, she is a distinguished professional with more than 25 years of experience in the healthcare industry, a TEDx speaker, and [...]